PRC2 inhibitor

DRUG CLASS:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

SMARCA4 mutation	Renal Cell Carcinoma	SMARCA4 mutation	Renal Cell Carcinoma	MRTX2219 Sensitive: D – Preclinical MRTX2219 Sensitive : D	MRTX2219 Sensitive: D – Preclinical MRTX2219 Sensitive : D
KDM6A mutation	Renal Cell Carcinoma	KDM6A mutation	Renal Cell Carcinoma	MRTX2219 Sensitive: D – Preclinical MRTX2219 Sensitive : D	MRTX2219 Sensitive: D – Preclinical MRTX2219 Sensitive : D
EZH2 W113C	Lymphoma	EZH2 W113C	Lymphoma	PRC2 inhibitor Sensitive: D – Preclinical PRC2 inhibitor Sensitive : D	PRC2 inhibitor Sensitive: D – Preclinical PRC2 inhibitor Sensitive : D

Associations(3)